drugset / Trial / NCT02388178
To Determine the Ability of a New Product Formulation to Remineralize an Early Caries Lesion by an In-situ Study
RandomizedCrossoverTriple-blindTreatment
Summary
This is a double blind, cross-over, controlled clinical trial utilizing thirty (30) adults to evaluate remineralization of early caries lesions.
Timeline
- Start
- 2015-04
- Primary completion
- 2015-07
- Completion
- 2015-07
Outcome
Outcome not reported
Stopped (Business): “The study was stopped due to business reasons.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Arginine | Other / unclassified | — | Oral |
| Subject | Fluoride | Other / unclassified | 1450 ppm | Oral |